Crowdonomics
Love Sun Body

Reg CF · Preferred Stock · Mar 2024

ClosedReg CFPreferred Equity
via WeFunderView campaign
Raised
$2.4K / $618K max
0% of ceiling
Investors
—
—
Post-money valuation
$29.9M
pre-money + amount raised

Raised over time

Cumulative raised
$3K$1K$0
Mar 18, 2024 · openedApr 28, 2024 · last reading
Deadline Apr 29, 2024 — 1 days out

Left axis: cumulative dollars raised. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2021–FY2022 · hover for source
$70K
−$789K
FY2021
$166K
−$812K
FY2022
RevenueNet income
Metric
FY2021 reviewed
FY2022 reviewed
Income statement
Revenue
$70,145
$165,785
Cost of goods sold
$112,307
$308,165
Gross margin
-60%
-86%
Net income
-$789,160
-$811,744
Taxes paid
$0
$0
Balance sheet
Cash
$431,026
$202,736
Accounts receivable
$2,878
$2,155
Total assets
$608,889
$396,915
Short-term debt
$48,734
$409,970
Long-term debt
$0
$0
Total liabilities
$48,734
$409,970
Other
Headcount
—
10

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$29.9M
Post-money$29.9M
Price / share$1.15
Shares offered54,348

Perks

First $300K of investments ill be at $0.92 per share and a $29.939M pre-money valuationfirst $300K

Offering details

Target$50,000
Max$618,000
Min investment$100
OpenedMar 18, 2024
DeadlineApr 29, 2024
ClosedApr 30, 2024
Days active43

Links & provenance

Source: Manual
0001670254-24-000034

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.